Back to Market返回行情

KLBF.JK PT Kalbe Farma Tbk.

JKTHealthcare
$695.00-3.47%ClosedMarket Cap: $31.45T

As of 2026-06-05 05:11

Why KLBF.JK matters now

PT Kalbe Farma Tbk. (KLBF.JK) is a US stock in Healthcare. The latest InvestLog snapshot shows $695.00 with -3.47% on the session and $31.45T in market capitalization.

Valuation context is available even where detailed statement rows are sparse: InvestLog currently shows P/E 8.69, gross margin 38.7%, and operating margin 12.3%.

InvestLog's latest related AI research is a Dividend Change note titled "KLBF.JK cuts dividend: 20.0 per share on 2026-06-04".

Valuation

View Details

P/E (TTM)

8.69

PEG

P/B

1.29

P/S

0.87

EV/EBITDA

5.19

DCF Value

FCF Yield

7.8%

Div Yield

2.9%

Margins & Returns

Gross Margin

38.7%

Operating Margin

12.3%

Net Margin

10.0%

ROE

15.6%

ROA

11.3%

ROIC

13.2%

Listing Info

Market

US

Exchange

JKT

Currency

USD

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

ID

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution and Logistic. It offers generic, branded, and licensed drugs, including Brainact, Cefspan, Mycoral, Cernevit, Cravit, Neuralgin, Broadced, Neurotam, Hemapo, and CPG that are distributed to hospitals, pharmacies, and drug stores. The company also provides over-the-counter drugs; energy drinks, ready-to-drink products, supplements, and other preventive products; and nutritional products for infants, toddlers, children, teenagers, adults, pregnant and lactating women, and elders, as well as for consumers with special medical needs. In addition, it offers contract services, including clinical study management, bioavailability/bioequivalence studies, and contract analysis to pharmaceutical companies; and animal health products, as well as operates Mitrasana Clinics, a health care service. Further, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia.